Oldest pages
Jump to navigation
Jump to search
Showing below up to 326 results in range #501 to #826.
View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)
- Disposal facility (22:02, 24 February 2021)
- Dose modifying factor (22:03, 24 February 2021)
- Exposure pathway (22:05, 24 February 2021)
- Radiological controlled area (22:07, 24 February 2021)
- Life Span Study (22:10, 24 February 2021)
- Detriment (19:17, 25 February 2021)
- Baseline disease rates (19:29, 25 February 2021)
- Biomarker (19:31, 25 February 2021)
- Case–control study (19:33, 25 February 2021)
- Deterministic effect (19:38, 25 February 2021)
- Dose and dose-rate effectiveness factor (15:54, 26 February 2021)
- Dose-threshold hypothesis (15:56, 26 February 2021)
- Tissue reaction (16:00, 26 February 2021)
- Doubling dose (17:10, 26 February 2021)
- Epigenetic effects (17:13, 26 February 2021)
- Excess absolute risk (17:16, 26 February 2021)
- Excess relative risk (17:25, 26 February 2021)
- Homologous recombination (17:26, 26 February 2021)
- Incidence (17:28, 26 February 2021)
- Induced genomic instability (17:30, 26 February 2021)
- Late normal tissue responses (17:31, 26 February 2021)
- LD 50/30 (17:33, 26 February 2021)
- Lifetime risk estimates (17:42, 26 February 2021)
- Linear dose response (17:43, 26 February 2021)
- Linear-quadratic dose response model (17:48, 26 February 2021)
- Stochastic effect (17:58, 26 February 2021)
- Nominal risk coefficient (19:29, 26 February 2021)
- Non-homologous end joining (19:30, 26 February 2021)
- Non-targeted effects (19:31, 26 February 2021)
- Normal tissue complication probability (19:33, 26 February 2021)
- Pooled analysis (19:34, 26 February 2021)
- Quasi-threshold dose (19:35, 26 February 2021)
- Reactive oxygen species (19:36, 26 February 2021)
- Recovery (cellular or tissue) (19:38, 26 February 2021)
- Reference Animal and Plant (19:43, 26 February 2021)
- Relative biological effectiveness (20:22, 26 February 2021)
- Relative risk (20:25, 26 February 2021)
- Risk coefficient (20:30, 26 February 2021)
- Targeted effects (20:32, 26 February 2021)
- Translocation (20:33, 26 February 2021)
- Radiation source (21:04, 26 February 2021)
- Dose-response function (14:57, 28 March 2021)
- Tissue weighting factor (21:32, 28 March 2021)
- Absorption (22:15, 28 March 2021)
- Activation (22:16, 28 March 2021)
- Activity (22:19, 28 March 2021)
- ICRPædia Guide to the System of Radiological Protection (21:44, 3 May 2021)
- Active detection system (19:35, 11 August 2021)
- Additional dose (19:36, 11 August 2021)
- Allometry (19:37, 11 August 2021)
- Commissioning (19:42, 11 August 2021)
- Compartment (environmental) (19:44, 11 August 2021)
- Accreditation (19:45, 11 August 2021)
- Backscatter detection system (19:48, 11 August 2021)
- Clearance (19:50, 11 August 2021)
- Concentration ratio (19:52, 11 August 2021)
- Containment (19:56, 11 August 2021)
- Cosmic radiation (19:57, 11 August 2021)
- Derived reference level (20:00, 11 August 2021)
- Derived limit (20:00, 11 August 2021)
- Derived consideration reference level (20:02, 11 August 2021)
- Designated area (20:03, 11 August 2021)
- Evacuation (20:07, 11 August 2021)
- Exclusion (20:08, 11 August 2021)
- Exposed individuals (20:09, 11 August 2021)
- Frequent flyer (20:11, 11 August 2021)
- Ground-level enhancement (20:12, 11 August 2021)
- ICRU 4-element tissue (20:14, 11 August 2021)
- ICRU sphere (20:17, 11 August 2021)
- Intervention (20:18, 11 August 2021)
- Licensee (20:20, 11 August 2021)
- National radon survey (20:20, 11 August 2021)
- Nominal value (20:21, 11 August 2021)
- Occupancy factor (20:22, 11 August 2021)
- Operating management (20:23, 11 August 2021)
- Potential exposure (23:17, 11 August 2021)
- Collective dose (23:18, 11 August 2021)
- Optimisation of protection (23:22, 11 August 2021)
- Practice (23:25, 11 August 2021)
- Principles of protection (23:25, 11 August 2021)
- Radioactive waste (23:29, 11 August 2021)
- Radiological attack (23:30, 11 August 2021)
- Radon progeny (23:30, 11 August 2021)
- Radon-prone area (23:31, 11 August 2021)
- Redox (23:31, 11 August 2021)
- Reference value (23:34, 11 August 2021)
- Safety (23:36, 11 August 2021)
- Region (23:36, 11 August 2021)
- Sealed source (23:38, 11 August 2021)
- Solar flare (23:59, 11 August 2021)
- Sheltering (00:00, 12 August 2021)
- Security (00:01, 12 August 2021)
- Security screening (00:02, 12 August 2021)
- Protection quantities (14:51, 12 August 2021)
- Source-related assessment (14:53, 12 August 2021)
- Superposition principle (14:55, 12 August 2021)
- Surface contamination (14:56, 12 August 2021)
- Thoron progeny (14:57, 12 August 2021)
- Transmission detection system (14:59, 12 August 2021)
- Trophic level (15:00, 12 August 2021)
- Waste management (15:05, 12 August 2021)
- Worker (15:08, 12 August 2021)
- Working level (15:14, 12 August 2021)
- Working level month (15:17, 12 August 2021)
- Adenoma (15:24, 12 August 2021)
- Air kerma at the patient entrance reference point (15:27, 12 August 2021)
- Apoptosis (15:29, 12 August 2021)
- AML/eto (15:30, 12 August 2021)
- Automatic exposure control (15:33, 12 August 2021)
- Brachytherapy (15:34, 12 August 2021)
- Bragg peak (15:37, 12 August 2021)
- Spread-out Bragg peak (15:39, 12 August 2021)
- Breakpoint cluster region/abelson (15:41, 12 August 2021)
- Broad beam therapy irradiation technique (15:44, 12 August 2021)
- Carers and comforters (15:48, 12 August 2021)
- Clinical audit (15:50, 12 August 2021)
- Clonogenic surviving fraction (15:52, 12 August 2021)
- Cobblestone area forming cell assay (15:53, 12 August 2021)
- Collimation (15:54, 12 August 2021)
- Cone beam computed tomography (15:56, 12 August 2021)
- Dental and maxillofacial imaging (16:01, 12 August 2021)
- Exposure index (16:03, 12 August 2021)
- Detector quantum efficiency (16:04, 12 August 2021)
- Diagnostic reference level (16:09, 12 August 2021)
- Dose-length product (16:11, 12 August 2021)
- DRL process (16:14, 12 August 2021)
- DRL quantity (16:18, 12 August 2021)
- Exogenous excretion (16:19, 12 August 2021)
- Functional subunits (16:24, 12 August 2021)
- Hounsfield unit (16:43, 12 August 2021)
- Accelerated fractionation (16:45, 12 August 2021)
- Hyperfractionation (16:45, 12 August 2021)
- Intensity-modulated radiotherapy (16:46, 12 August 2021)
- Local DRL (16:49, 12 August 2021)
- National DRL (16:50, 12 August 2021)
- DRL value (16:51, 12 August 2021)
- Mean glandular dose (17:28, 12 August 2021)
- Multi-detector computed tomography (17:31, 12 August 2021)
- Multifactorial diseases (17:31, 12 August 2021)
- Multitarget equation (17:37, 12 August 2021)
- Noise (17:38, 12 August 2021)
- Notification value (17:41, 12 August 2021)
- Nuclear medicine (17:42, 12 August 2021)
- Molecular imaging (17:43, 12 August 2021)
- Organ at risk (17:44, 12 August 2021)
- Oxygen enhancement ratio (17:45, 12 August 2021)
- Pencil beam (17:46, 12 August 2021)
- Pilomatricoma (17:47, 12 August 2021)
- Potential recoverability correction factor (17:49, 12 August 2021)
- Quality control testing (17:51, 12 August 2021)
- Radiation-induced second cancer (17:52, 12 August 2021)
- Radiation-induced secondary malignancy (17:53, 12 August 2021)
- Ras (17:55, 12 August 2021)
- Rb (17:56, 12 August 2021)
- Referrer (17:57, 12 August 2021)
- Reference air kerma (17:59, 12 August 2021)
- Regional diagnostic reference levels (18:01, 12 August 2021)
- Registry (18:02, 12 August 2021)
- Relative survival (18:03, 12 August 2021)
- Secondary radiation (18:04, 12 August 2021)
- Shielding (18:05, 12 August 2021)
- Size-specific dose estimate (18:06, 12 August 2021)
- Slice (18:07, 12 August 2021)
- Standard-size adult (18:09, 12 August 2021)
- Stem cell (18:10, 12 August 2021)
- Teratocarcinoma (18:11, 12 August 2021)
- Time-resolved computed tomography (18:13, 12 August 2021)
- Tolerance dose (18:14, 12 August 2021)
- Digital breast tomosynthesis (18:15, 12 August 2021)
- Treatment preparation in radiotherapy (18:16, 12 August 2021)
- Typical value (18:18, 12 August 2021)
- Absorbed fraction (18:24, 12 August 2021)
- Source region (18:27, 12 August 2021)
- Activity median aerodynamic diameter (18:29, 12 August 2021)
- Ambient dose equivalent (18:30, 12 August 2021)
- Annual intake (18:31, 12 August 2021)
- Annual limit on intake (18:37, 12 August 2021)
- Derived air concentration (18:41, 12 August 2021)
- Biological half-life (18:43, 12 August 2021)
- Bronchiolar region (18:44, 12 August 2021)
- Charged-particle equilibrium (18:45, 12 August 2021)
- Collective effective dose (19:04, 12 August 2021)
- Compartment (19:06, 12 August 2021)
- Cross section (19:10, 12 August 2021)
- Cumulative dose (19:11, 12 August 2021)
- Deposition (19:13, 12 August 2021)
- Derived investigation level (19:14, 12 August 2021)
- Directional dose equivalent (19:16, 12 August 2021)
- Distribution coefficient (19:18, 12 August 2021)
- Dose (19:22, 12 August 2021)
- Absorbed dose (19:22, 12 August 2021)
- Equivalent dose (19:32, 12 August 2021)
- Dose commitment (19:40, 12 August 2021)
- Dose conversion convention (19:46, 12 August 2021)
- Dose conversion factor (19:47, 12 August 2021)
- Dose of record (E) (19:50, 12 August 2021)
- Dose of record Hp (10) (19:52, 12 August 2021)
- Dose per content function (18:26, 17 August 2021)
- DS86 (18:29, 17 August 2021)
- DS02 (18:29, 17 August 2021)
- Endosteum (18:34, 17 August 2021)
- Equieffective dose (18:41, 17 August 2021)
- Equilibrium equivalent concentration (18:43, 17 August 2021)
- Equilibrium factor (02:06, 18 August 2021)
- Excretion rate (instantaneous) (02:08, 18 August 2021)
- Expanded and aligned radiation field (02:11, 18 August 2021)
- Expanded radiation field (02:12, 18 August 2021)
- Exposure (in the context of inhalation) (02:14, 18 August 2021)
- Extrathoracic airways (02:18, 18 August 2021)
- Human Respiratory Tract Model (02:31, 18 August 2021)
- Human Alimentary Tract Model (02:33, 18 August 2021)
- Gray (02:34, 18 August 2021)
- Intake (02:39, 18 August 2021)
- Kerma approximation (16:58, 18 August 2021)
- Low linear energy transfer radiation (17:19, 18 August 2021)
- High linear energy transfer radiation (17:21, 18 August 2021)
- Linear energy transfer (17:23, 18 August 2021)
- Marrow cellularity (17:25, 18 August 2021)
- Count median diameter (17:38, 18 August 2021)
- Mass median diameter (17:39, 18 August 2021)
- Activity median thermodynamic diameter (17:41, 18 August 2021)
- Thermodynamic diameter (17:42, 18 August 2021)
- Measured quantity (17:45, 18 August 2021)
- Organ/tissue absorbed dose (18:14, 18 August 2021)
- OLINDA/EXM (18:17, 18 August 2021)
- Other (systemic) tissues (18:23, 18 August 2021)
- Particle transport (18:24, 18 August 2021)
- Dose equivalent (18:34, 18 August 2021)
- Organ dose equivalent (18:36, 18 August 2021)
- Personal dose equivalent (18:42, 18 August 2021)
- Operational quantity (18:45, 18 August 2021)
- Phantom (18:46, 18 August 2021)
- Potential alpha energy concentration (18:48, 18 August 2021)
- Quality factor (19:14, 18 August 2021)
- Radiation weighting factor (19:25, 18 August 2021)
- Sievert (19:36, 18 August 2021)
- Specific effective energy (19:40, 18 August 2021)
- Dose coefficient (18:10, 19 August 2021)
- Dose conversion coefficient (18:10, 19 August 2021)
- Effective dose (18:28, 19 August 2021)
- Reference individual (18:34, 19 August 2021)
- Reference parameter value (18:35, 19 August 2021)
- Reference Person (18:39, 19 August 2021)
- Reference phantom (18:45, 19 August 2021)
- Reference worker (18:46, 19 August 2021)
- S coefficient (radiation weighted) (18:57, 19 August 2021)
- Specific absorbed fraction (19:01, 19 August 2021)
- Spongiosa (19:04, 19 August 2021)
- Thoracic airways (19:10, 19 August 2021)
- Investigation level (19:11, 19 August 2021)
- Threshold level (19:12, 19 August 2021)
- Non-maleficence (19:38, 19 August 2021)
- Dignity (19:51, 19 August 2021)
- Beneficence (19:51, 19 August 2021)
- Prudence (19:53, 19 August 2021)
- Equity (19:55, 19 August 2021)
- ALARA (20:02, 19 August 2021)
- Optimisation (20:03, 19 August 2021)
- Alimentary tract (20:14, 19 August 2021)
- Low Earth orbit (01:58, 20 August 2021)
- Kerma (14:12, 7 September 2021)
- Employer (14:15, 7 September 2021)
- Justice (14:18, 7 September 2021)
- Justification (14:18, 7 September 2021)
- Kp index (14:22, 7 September 2021)
- Fairness (14:23, 7 September 2021)
- Field-size effect (Volume effect) (14:23, 7 September 2021)
- Flexible tissues (14:24, 7 September 2021)
- Fluoroscopically guided interventions (14:24, 7 September 2021)
- Fluence (14:24, 7 September 2021)
- Fluoroscopically or computed tomography guided interventions (14:24, 7 September 2021)
- Forbiddenness (14:25, 7 September 2021)
- Fractional absorption in the gastrointestinal tract (14:25, 7 September 2021)
- Fractionation (14:25, 7 September 2021)
- Fractionation and dose delivery patterns (14:26, 7 September 2021)
- Fractionation sensitivity (14:26, 7 September 2021)
- Galactic cosmic radiation (14:27, 7 September 2021)
- Gamma ray (14:27, 7 September 2021)
- Gastrointestinal syndrome (14:27, 7 September 2021)
- Gastrulation (14:27, 7 September 2021)
- Gastroschisis (14:28, 7 September 2021)
- GATA binding protein 2 (14:28, 7 September 2021)
- Genomic integrity (14:28, 7 September 2021)
- Rigidity threshold (14:29, 7 September 2021)
- Graded approach (14:29, 7 September 2021)
- Graft vs host disease (14:29, 7 September 2021)
- Granulocyte colony-stimulating factor (14:30, 7 September 2021)
- Granulocyte-macrophage colony-stimulating factor (14:30, 7 September 2021)
- Growth factor (14:31, 7 September 2021)
- Growth fraction (14:31, 7 September 2021)
- Growth hormone (somatotropin) (14:32, 7 September 2021)
- X ray (14:33, 7 September 2021)
- Xerostomia (14:33, 7 September 2021)
- Value judgement (14:33, 7 September 2021)
- Valvular heart disease (14:34, 7 September 2021)
- Virtue ethics (14:34, 7 September 2021)
- Voxel phantom (14:34, 7 September 2021)
- Unattached fraction (14:55, 7 September 2021)
- Unsealed source (14:56, 7 September 2021)
- Upper reference levels (14:56, 7 September 2021)
- Uptake (14:56, 7 September 2021)
- Utilitarian ethics (14:57, 7 September 2021)
- Cohort study (14:21, 3 October 2021)
- Lag (14:24, 3 October 2021)
- Lifetime risk (14:28, 3 October 2021)
- Absolute risk (14:29, 3 October 2021)
- Risk (14:29, 3 October 2021)
- Secretory cells (14:31, 3 October 2021)
- ICRP Glossary (14:37, 3 October 2021)
- ICRP Publication 140 (17:08, 3 October 2021)
- ICRP Publication 141 (17:10, 3 October 2021)
- ICRP Publication 142 (17:10, 3 October 2021)
- ICRP Publication 143 (17:11, 3 October 2021)
- ICRP Publication 144 (17:11, 3 October 2021)
- ICRP Publication 145 (17:12, 3 October 2021)
- ICRP Publication 146 (17:12, 3 October 2021)
- ICRP Publication 147 (17:13, 3 October 2021)
- ICRP Publication 148 (17:13, 3 October 2021)
- ICRP Publication 149 (17:13, 3 October 2021)
- ICRP Publication 150 (17:14, 3 October 2021)
- ICRP Publication 151 (17:14, 3 October 2021)
- ICRP Publication 152 (17:14, 3 October 2021)
- ICRP Publication 153 (17:15, 3 October 2021)
- ICRP Publication 154 (17:15, 3 October 2021)
- ICRP Publication 155 (17:15, 3 October 2021)
- ICRP publications (17:57, 3 October 2021)